The health care scenario in India is changing rapidly. There is a change in the disease profile, an ever increasing difference between rural and urban India and an increased interest in investments into health care from ...

In this seminar, the speaker will talk about emerging life science/healthcare innovation ecosystem and different pillars of this ecosystem at BioCluster in Bangalore. The seminar will have a broader overview of this ...

Primum non nocere is generally understood to be the cornerstone of the practice of medicine, but at times it is lost sight of, especially in hospitals that do not encourage a culture of patient safety. This term was first ...

In India, approximately 22 million children are affected by developmental delays that frequently go undetected or are detected late, at extensive cost to parents and irreversible damage to the child. In addition, 30% do ...

The aim of this talk is to provide various case studies in health and medical science which have come through my international, industrial and interdisciplinary collaborations. The first case study is concerned with saving ...

Pharmaceutical industry is entering an exciting new era in drug development with recent scientific and technological advancement. Research methods are evolving and we have many promising prospects on the horizon. The ...

Currently valued at USD 14.7 bn the domestic Pharmaceutical Market is growing at 14%. It is a highly fragmented market with over 3,000 companies (of which 550 are covered by IMS) and over 30,000 brands. Indian companies ...